- Home
- BBIO vs PVH Comparison
BBIO vs PVH Comparison
Compare BBIO & PVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- PVH
- Stock Information
- Founded
- BBIO 2015
- PVH 1881
- Country
- BBIO United States
- PVH United States
- Employees
- BBIO N/A
- PVH N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- PVH Apparel
- Sector
- BBIO Health Care
- PVH Consumer Discretionary
- Exchange
- BBIO Nasdaq
- PVH Nasdaq
- Market Cap
- BBIO 6.7B
- PVH 6.1B
- IPO Year
- BBIO 2019
- PVH N/A
- Fundamental
- Price
- BBIO $34.25
- PVH $83.76
- Analyst Decision
- BBIO Strong Buy
- PVH Buy
- Analyst Count
- BBIO 12
- PVH 15
- Target Price
- BBIO $57.09
- PVH $104.93
- AVG Volume (30 Days)
- BBIO 2.9M
- PVH 1.3M
- Earning Date
- BBIO 04-29-2025
- PVH 06-04-2025
- Dividend Yield
- BBIO N/A
- PVH 0.18%
- EPS Growth
- BBIO N/A
- PVH N/A
- EPS
- BBIO N/A
- PVH 10.56
- Revenue
- BBIO $127,415,000.00
- PVH $8,652,900,000.00
- Revenue This Year
- BBIO $89.10
- PVH $0.94
- Revenue Next Year
- BBIO $57.07
- PVH $2.10
- P/E Ratio
- BBIO N/A
- PVH $7.93
- Revenue Growth
- BBIO N/A
- PVH N/A
- 52 Week Low
- BBIO $21.62
- PVH $59.28
- 52 Week High
- BBIO $39.54
- PVH $124.68
- Technical
- Relative Strength Index (RSI)
- BBIO 50.58
- PVH 58.41
- Support Level
- BBIO $31.77
- PVH $79.60
- Resistance Level
- BBIO $33.93
- PVH $87.90
- Average True Range (ATR)
- BBIO 1.28
- PVH 2.57
- MACD
- BBIO -0.09
- PVH -0.04
- Stochastic Oscillator
- BBIO 57.14
- PVH 56.06
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About PVH PVH Corp.
PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites and about 1,500 stores, licenses its brands to third parties, and distributes its merchandise through department stores and other wholesale accounts. The firm traces its history to 1881 and is based in New York City.